Page 3 - Euronext News Today

US stocks were mixed at the end of the first trading day in June as weak manufacturing data indicated the US economy may be weakening

ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3 Sarclisa, in combination

One of the best ways to tap into a growing market is to invest in its supply chain. Being a supplier to a big company can be a tough existence, but for those that supply niche, value-added and enabling products and services, big profits can be made.

Euronext (OTCMKTS:EUXTF – Get Free Report) was the recipient of a large decrease in short interest in May. As of May 15th, there was short interest totalling 11,400 shares, a decrease of 8.1% from the April 30th total of 12,400 shares. Based on an average daily volume of 600 shares, the days-to-cover ratio is currently […]

Camden National Bank acquired a new position in Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 1,341 shares of the company’s stock, valued at approximately $212,000. Other institutional investors […]

The former chief executive of the London Stock Exchange (LSE) has urged the next government to save the UK’s struggling equities market as he warned of a bleak future for the City without additional support.

Schulz Wealth LTD. acquired a new position in shares of Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 2,140 shares of the company’s stock, valued at approximately $338,000. A number of other hedge […]

Schulz Wealth LTD. purchased a new stake in shares of Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 2,140 shares of the company’s stock, valued at approximately $338,000. Several other large investors have also […]

31.05.2024 - Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3 trials demonstrating Dupixent significantly reduced exacerbations and improved lung function If approved, ...

Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3 trials demonstrating Dupixent significantly reduced exacerbations and improved...